Search

Your search keyword '"Lorenzi M"' showing total 1,073 results

Search Constraints

Start Over You searched for: Author "Lorenzi M" Remove constraint Author: "Lorenzi M"
1,073 results on '"Lorenzi M"'

Search Results

3. Exploiting plant biodiversity to tackle colorectal cancer and non-alcoholic fatty liver disease

4. Regional flux analysis for discovering and quantifying anatomical changes: An application to the brain morphometry in Alzheimer's disease

5. WASPnest : a worldwide assessment of social Polistine nesting behavior

10. 21P Bevacizumab plus atezolizumab and chemotherapy in NSCLC harbouring EGFR mutation previously treated with EGFR tyrosine kinase inhibitor: The BACH-NET study

12. FLamby:Datasets and Benchmarks for Cross-Silo Federated Learning in Realistic Healthcare Settings

13. 1584P Immune-related adverse events (irAEs) in advanced non-small cell lung cancer (aNSCLC) in a real-world analysis: A risk prediction nomogram

14. P1.15-06 Immune-Checkpoint Inhibitors-Related Colitis in Advanced Non-small Cell Lung Cancer Patients: A Real-World Analysis

15. EP08.01-012 First-line Chemo-Immunotherapy in Advanced Non-Small Cell Lung Cancer with 0-49% PD-L1: A Real-world Experience

17. EP08.02-104 Osimertinib in Untreated EGFR-Mutant Non-small Cell Lung Cancers: Overall Survival and Budget Impact Analysis in Real-World

25. 40P Immune-related adverse events (irAEs) in advanced non-small cell lung cancer (aNSCLC) patients (pts): A real-world analysis

26. 63P Immune-related adverse events (irAEs) in advanced non-small cell lung cancer (aNSCLC) patients (pts): Neutrophil to lymphocyte ratio (NLR) and the risk for toxicity recurrence

28. L’impatto dell’uso dei trattamenti non compresi nelle classi di rimborsabilità nella presa in carico dei malati rari: uno studio in campo reale [The impact of the use of treatments not included in the reimbursement classes in the care of rare patients: a real world study]

29. The sarcopenia and physical frailty in older people: multi-component treatment strategies (SPRINTT) project: description and feasibility of a nutrition intervention in community-dwelling older Europeans

31. Quality of life in advanced colorectal cancer

39. Detection of circulating immunosuppressive cytokines in malignant pleural mesothelioma patients for prognostic stratification

41. Real-world data on treatment outcomes in EGFR-mutant non-small-cell lung cancer patients receiving osimertinib in second or further lines

42. OCT Signal Enhancement with Deep Learning.

43. Characterization of BMS-911543, a functionally selective small-molecule inhibitor of JAK2

50. 149P First-line (1L) osimertinib in EGFR mutant (mut) advanced non-small cell lung cancer (aNSCLC) patients (pts): Progression (PD) pattern and safety in the real-world (RW)

Catalog

Books, media, physical & digital resources